New York State Common Retirement Fund Kymera Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

$74.6 Billion
Q4 2024

A detailed history of New York State Common Retirement Fund transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, New York State Common Retirement Fund holds 14,549 shares of KYMR stock, worth $473,424. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,549

Previous 15,649 7.03%

Holding current value

$473,424

Previous $741,000 21.05%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	SELL	$39.06 - $51.84 $42,966 - $57,024	-1,100 Reduced 7.03%	14,549 $585,000
Q3 2024 Oct 28, 2024	SELL	$30.16 - $52.4 $156,832 - $272,480	-5,200 Reduced 24.94%	15,649 $741,000
Q2 2024 Jul 31, 2024	BUY	$29.85 - $39.42 $124,534 - $164,460	4,172 Added 25.02%	20,849 $622,000
Q1 2024 May 07, 2024	BUY	$22.9 - $43.57 $1,305 - $2,483	57 Added 0.34%	16,677 $670,000
Q4 2023 Feb 01, 2024	SELL	$10.97 - $26.84 $3,115 - $7,622	-284 Reduced 1.68%	16,620 $423,000
Q3 2023 Nov 07, 2023	BUY	$13.9 - $23.88 $2,057 - $3,534	148 Added 0.88%	16,904 $235,000
Q2 2023 Aug 07, 2023	SELL	$22.4 - $34.92 $92,624 - $144,394	-4,135 Reduced 19.79%	16,756 $385,000
Q1 2023 May 02, 2023	SELL	$24.84 - $38.75 $152,691 - $238,196	-6,147 Reduced 22.73%	20,891 $619,000
Q4 2022 Jan 30, 2023	BUY	$19.57 - $30.92 $136 - $216	7 Added 0.03%	27,038 $675,000
Q3 2022 Nov 08, 2022	BUY	$20.91 - $34.27 $1,630 - $2,673	78 Added 0.29%	27,031 $588,000
Q2 2022 Aug 04, 2022	SELL	$14.13 - $42.55 $607 - $1,829	-43 Reduced 0.16%	26,953 $531,000
Q1 2022 May 05, 2022	BUY	$35.3 - $64.68 $88,355 - $161,894	2,503 Added 10.22%	26,996 $1.14 Million
Q4 2021 Feb 02, 2022	BUY	$49.91 - $65.56 $92,682 - $121,744	1,857 Added 8.2%	24,493 $1.56 Million
Q3 2021 Nov 02, 2021	SELL	$47.8 - $66.66 $107,119 - $149,385	-2,241 Reduced 9.01%	22,636 $1.33 Million
Q2 2021 Aug 02, 2021	BUY	$31.08 - $51.95 $474,809 - $793,640	15,277 Added 159.14%	24,877 $1.21 Million
Q1 2021 May 11, 2021	BUY	$35.64 - $85.46 $60,588 - $145,282	1,700 Added 21.52%	9,600 $373,000
Q4 2020 Feb 08, 2021	BUY	$28.07 - $87.83 $221,753 - $693,857	7,900 New	7,900 $490,000

Others Institutions Holding KYMR

# of Institutions

186

Shares Held

65.6M

Call Options Held

49.6K

Put Options Held

17K

View Full List

About Kymera Therapeutics, Inc.

Ticker KYMR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,705,800
Market Cap $1.78B
Description
Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...

More about KYMR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account

New York State Common Retirement Fund Kymera Therapeutics, Inc. Transaction History